AP898A - Benzamidine treatment of dementia associated with Aids Virus (HIV-1) infection. - Google Patents
Benzamidine treatment of dementia associated with Aids Virus (HIV-1) infection. Download PDFInfo
- Publication number
- AP898A AP898A APAP/P/1998/001368A AP9801368A AP898A AP 898 A AP898 A AP 898A AP 9801368 A AP9801368 A AP 9801368A AP 898 A AP898 A AP 898A
- Authority
- AP
- ARIPO
- Prior art keywords
- butyl
- acetamidobenzamide
- dementia
- pharmaceutical composition
- hiv
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1571096P | 1996-04-17 | 1996-04-17 | |
PCT/US1997/006351 WO1997038684A1 (en) | 1996-04-17 | 1997-04-17 | Benzamide treatment of dementia associated with aids virus (hiv-1) infection |
Publications (2)
Publication Number | Publication Date |
---|---|
AP9801368A0 AP9801368A0 (en) | 1998-12-31 |
AP898A true AP898A (en) | 2000-11-17 |
Family
ID=21773101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1998/001368A AP898A (en) | 1996-04-17 | 1997-04-17 | Benzamidine treatment of dementia associated with Aids Virus (HIV-1) infection. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0912171A1 (zh) |
CN (1) | CN1218399A (zh) |
AP (1) | AP898A (zh) |
AU (1) | AU720578B2 (zh) |
BR (1) | BR9708720A (zh) |
CA (1) | CA2252403A1 (zh) |
IS (1) | IS4868A (zh) |
NZ (1) | NZ332438A (zh) |
OA (1) | OA10901A (zh) |
TW (1) | TW412421B (zh) |
WO (1) | WO1997038684A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003211118A1 (en) | 2002-02-13 | 2003-09-04 | Creagri, Inc. | Method and composition for treatment of inflammation and aids-associated neurological disorders |
JP6750177B2 (ja) * | 2015-12-11 | 2020-09-02 | ロート製薬株式会社 | アントラニルアミド誘導体およびそれを含有するtlr3が関与する疾患の治療剤 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995028153A1 (en) * | 1994-04-14 | 1995-10-26 | Centaur Pharmaceuticals, Inc. | Benzamide-containing pharmaceutical compositions |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL117629A (en) * | 1995-04-03 | 2000-08-13 | Centaur Pharmaceuticals Inc | Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof |
-
1997
- 1997-04-17 BR BR9708720-3A patent/BR9708720A/pt not_active Application Discontinuation
- 1997-04-17 AU AU27322/97A patent/AU720578B2/en not_active Ceased
- 1997-04-17 WO PCT/US1997/006351 patent/WO1997038684A1/en not_active Application Discontinuation
- 1997-04-17 EP EP97921220A patent/EP0912171A1/en not_active Ceased
- 1997-04-17 NZ NZ332438A patent/NZ332438A/en unknown
- 1997-04-17 AP APAP/P/1998/001368A patent/AP898A/en active
- 1997-04-17 TW TW86104991A patent/TW412421B/zh active
- 1997-04-17 CN CN 97194582 patent/CN1218399A/zh active Pending
- 1997-04-17 CA CA 2252403 patent/CA2252403A1/en not_active Abandoned
-
1998
- 1998-10-16 OA OA9800198A patent/OA10901A/en unknown
- 1998-10-16 IS IS4868A patent/IS4868A/is unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995028153A1 (en) * | 1994-04-14 | 1995-10-26 | Centaur Pharmaceuticals, Inc. | Benzamide-containing pharmaceutical compositions |
Also Published As
Publication number | Publication date |
---|---|
AU2732297A (en) | 1997-11-07 |
CN1218399A (zh) | 1999-06-02 |
BR9708720A (pt) | 2000-01-04 |
OA10901A (en) | 2002-02-14 |
IS4868A (is) | 1998-10-16 |
AP9801368A0 (en) | 1998-12-31 |
NZ332438A (en) | 2001-02-23 |
WO1997038684A1 (en) | 1997-10-23 |
AU720578B2 (en) | 2000-06-08 |
CA2252403A1 (en) | 1997-10-23 |
EP0912171A1 (en) | 1999-05-06 |
TW412421B (en) | 2000-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060100461A1 (en) | Acetamidobenzamide compounds for neurodegenerative disorders | |
US5659082A (en) | Nitro- and aminobenzamide compounds for neurodegenerative disorders | |
JP2010520223A (ja) | 発作関連障害のための組成物および方法 | |
AP898A (en) | Benzamidine treatment of dementia associated with Aids Virus (HIV-1) infection. | |
JP3479658B2 (ja) | 神経変性障害処置のためのベンズアミド | |
US6034112A (en) | Use of flupirtine the prophylaxis and therapy of diseases associated with an impairment of the hematopoetic cell system | |
MXPA98008661A (en) | Benzamide treatment of associated dementia the infection for the virus of the acquired immunodeficiency syndrome (human immunodeficiency virus) | |
US6077870A (en) | Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders | |
US5955506A (en) | Benzamides for neurodegenerative disorder treatment | |
US5914350A (en) | Pharmaceutical compositions of nitro- and aminobenzamide compounds for neurodegenerative disorders | |
AU725432B2 (en) | Nitrone free radical trap treatment of dementia associated with AIDS virus (HIV-1) infection | |
Pritchard et al. | The biological bases of pharmacological therapies in Down syndrome |